COG AGCT0132 (CINJ 110405): A PHASE III STUDY OF REDUCED THERAPY IN THE TREATMENT OF CHILDREN WITH LOW AND INTERMEDIATE RISK EXTRACRANIAL GERM CELL TUMORS.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bleomycin; Cisplatin; Etoposide
- Indications Germ cell and embryonal neoplasms
- Focus Adverse reactions; Therapeutic Use
- 13 Jul 2021 Biomarkers information updated
- 03 Aug 2012 Planned end date changed from 1 Oct 2010 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 03 Aug 2012 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.